News

3Q20 Earnings Release

São Paulo, November 12th, 2020 - Alliar - Centro de Imagem Diagnósticos S.A. hereby announces its 3Q20 results.

Highlights:

  • 3Q20 marked Alliar’s return to growth and profitability as of September;
  • September had the best performance of 2020, with a 2.0% YoY increase in revenue a.a. and net income of R$3.3 million;
  • Gross revenue totaled R$278.8 million in 3Q20, up by 85% over 2Q20 and slightly lower than in 3Q19 (-6% YoY);
  • The Clinical Analysis segment reported record revenue of R$56.7 million, up by 44% YoY;
  • iDr continues its growth trajectory (+49% YoY) and already accounted for 1% of Alliar’s total revenue;
  • The private segment reported record revenue for yet another quarter, up by 58% YoY, an important milestone for the diversification of payment sources;
  • Remote channels accounted for 7.5% of consolidated revenue. Exams volume grew 40% over 2Q20;
  • Gross revenue totaled R$278.9 million and adjusted EBITDA amounted to R$56.7 million, leading to a net loss (Shareholders) of R$-3.8 million;
  • Debt reprofiling of R$ 194 mn of short-term debt, with extended terms and reduced rates, with R$ 74 mn already reflected in this balance sheet. The renegotiations reduce the maturities of loans and financing in the next 12 months and reinforce the Company‘s financial strength;
  • Robust cash position at R$212.8 million at the end of the quarter.


Click here to access the Earnings Release.

Conference Call in Portuguese

November 13th, 2020

12:30 p.m. (Local time)
10:30 a.m. (NY time)
Phone: +55 (11) 2188-0155
Code: Alliar
Webcast: click here

IR Contact

Sami Foguel
CEO / IRO
Email:
ri@alliar.com